In vitro radiosensitization of breast cancer with hypoxia-activated prodrugs.

Aiyappa-Maudsley, Radhika; Elsalem, Lina; Ibrahim, Ali I M; Pors, Klaus; Martin, Stewart G

Aiyappa-Maudsley, Radhika; Elsalem, Lina; Ibrahim, Ali I M; Pors, Klaus; Martin, Stewart G.

Afiliación

Aiyappa-Maudsley R; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham, UK.
Elsalem L; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, William Henry Duncan Building, Liverpool, UK.
Ibrahim AIM; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK.
Pors K; Jordan University of Science and Technology, Faculty of Medicine, Department of Pharmacology, Irbid, Jordan.
Martin SG; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK.

J Cell Mol Med ; 26(16): 4577-4590, 2022 08.

Article en En | MEDLINE | ID: mdl-35841287

Asunto(s)

Profármacos; Neoplasias de la Mama Triple Negativas; Antraquinonas/farmacología; Hipoxia de la Célula; Línea Celular Tumoral; Humanos; Hipoxia/tratamiento farmacológico; Profármacos/metabolismo; Profármacos/farmacología; Profármacos/uso terapéutico; Neoplasias de la Mama Triple Negativas/tratamiento farmacológico; Neoplasias de la Mama Triple Negativas/metabolismo; Neoplasias de la Mama Triple Negativas/radioterapia

Palabras clave

HAPs; TNBC; breast cancer; hypoxia; hypoxia-activated prodrugs; luminal; radiotherapy; triple negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Neoplasias de la Mama Triple Negativas Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google